HANA FINANCIAL INVESTMENT
413. SUMMARY ACCESS DENIAL ACTIONS (in part)
413.A. Authority to Deny Access
The Chief Regulatory Officer or his delegate, upon a good faith determination that there are substantial reasons to believe that such immediate action is necessary to protect the best interests of the Exchange, may order that: 1) any party be denied access to any or all CME Group markets; 2) any party be denied access to the Globex platform; 3) any party be denied access to any other electronic trading or clearing platform owned or controlled by CME Group; or 4) any Member be immediately removed from any trading floor owned or controlled by CME Group.
On May 21, 2018, CME Group’s Market Regulation Department (“Market Regulation”), through its Chief Regulatory Officer, summarily denied Hana Financial Investment (“Hana”) direct and indirect access to all CME Group markets, including the CME Globex electronic trading platform (“Globex”), any other electronic trading or clearing platform owned or controlled by CME Group, and all trading floors owned or controlled by CME Group. The summary access denial prohibited Hana, and anyone through Hana accounts, from trading, placing orders, and controlling or directing the trading for any person, entity, or account in any CME Group exchange product. Notwithstanding the foregoing, open positions at Hana’s clearing firms were permitted to be liquidated by the clearing firms upon the request of Hana or Hana’s customers. On June 13, 2018, the Chief Regulatory Officer amended the access denial to permit Hana to trade for its proprietary accounts.
Since June 13, 2018, Hana has demonstrated to Market Regulation an ability to comply with exchange rules with respect to reporting positions in separate customers’ accounts to its Clearing Member Firms on a gross basis (to the extent such accounts are independently owned and controlled), identifying account owners and authorized traders for accounts, and providing accurate and complete information in response to Market Regulation inquires.
The Chief Regulatory Officer hereby amends this action to reflect an end to the access denial effective on trade date July 6, 2018.
July 6, 2018